Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Wuxi Biologics
Research and Development in Biotechnology (except Nanobiotechnology)ChinaPNK: WXXWY
Last verified 6 months agowuxibiologics.com
Wuxi Biologics, a leading global player in the biotechnology sector, is headquartered in Wuxi, China. Founded in 2010, the company has rapidly established itself as a key provider of research and development services in biotechnology, excluding nanobiotechnology. With a strong presence in major operational regions across Asia, Europe, and North America, Wuxi Biologics focuses on offering comprehensive solutions for biologics development, including cell line development, process development, and analytical services.
The company is renowned for its innovative approach and state-of-the-art facilities, which enable it to deliver high-quality biologics at an accelerated pace. Wuxi Biologics has achieved significant milestones, including numerous partnerships with leading pharmaceutical companies, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to excellence and a robust portfolio of services, Wuxi Biologics continues to drive advancements in biotechnology.
55
DitchCarbon score
+29 vs industry average
Wuxi Biologics’s score of 55 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Wuxi Biologics?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Research and Development in Biotechnology (except Nanobiotechnology) is among the most carbon-intensive industries
Industry performance
0.198
20182025
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Wuxi Biologics's reported carbon emissions
WuXi Biologics, headquartered in China, is in the Research and Development in Biotechnology industry. The company reported its most recent Scope 1 and 2 emissions data for 2025, totalling 229,730,000 kg CO2e (44,125,000 kg CO2e for Scope 1 and 185,605,000 kg CO2e for Scope 2).
The company has set several climate commitments. WuXi Biologics aims to reduce its Scope 1 and Scope 2 GHG emission intensity by 50% (tonnes/RMB10,000) by 2030, using a 2020 base year.
Through its Science Based Targets initiative (SBTi) commitments, WuXi Biologics (Cayman) Inc. has set both near-term and long-term targets. For near-term, it commits to reduce absolute Scope 1 and 2 GHG emissions by 58.8% by 2034 from a 2024 base year. Additionally, it aims to reduce Scope 3 GHG emissions, covering purchased goods and services, by 63.8% per kg of product produced within the same timeframe. For long-term, WuXi Biologics (Cayman) Inc. commits to reach net-zero greenhouse gas emissions across its value chain by 2050. This includes reducing absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2024 base year. It also commits to reducing absolute Scope 3 GHG emissions covering purchased goods and services, capital goods, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, and employee commuting by 90% within the same timeframe.
Assessing Wuxi Biologics as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Wuxi Biologics and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Wuxi Biologics’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
6 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Wuxi Biologics6 months ago
55
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Wuxi Biologics’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more